Device / Technology News

RSS

Study reveals effectiveness of cognitive testing by telephone in elderly individuals

Cognitive testing by telephone in elderly individuals is generally as effective as in-person testing, according to a new study by Effie M. Mitsis, PhD, Assistant Professor of Psychiatry at Mount Sinai School of Medicine and part of Mount Sinai's Alzheimer's Disease Research Center. The study will appear in the International Journal of Geriatric Psychiatry.

16 Sep 2009

EHNAC HNAP accreditation for Capario

Capario, a provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, announced today that it has again achieved full accreditation with the Healthcare Network Accreditation Program (HNAP) from the Electronic Healthcare Network Accreditation Commission (EHNAC).

16 Sep 2009

PsoriasisDX Genetic Test for Psoriatic arthritis launched

The first genetic test for Psoriatic arthritis (PsA) is being launched today by PsoriasisDX, LLC, a subsidiary of molecular dermatology research and development innovator PharmaGenoma, Inc. PsA is a progressive irreversible joint disease associated with psoriasis. It is estimated that 20% to 40% of psoriasis patients will eventually develop PsA.

16 Sep 2009

AS&E receives order for cargo X-ray inspection systems

American Science and Engineering, Inc. (AS&E®) (NASDAQ: ASEI), a leading worldwide supplier of innovative X-ray detection solutions, announced today that it has received an $18.8 million order for cargo X-ray inspection systems from an unnamed government agency to screen cargo and vehicles for explosive threats and contraband at border crossings.

16 Sep 2009

Mobetron portable radiation therapy system for breast cancer treatment

One minute of radiation in the operating room (OR) could save the lives of thousands of women being treated for breast cancer in the US today. According to a growing body of research, a 60-second course of radiation therapy delivered during surgery dramatically improves results. But, until recently, logistical and administrative difficulties prevented most patients from receiving this crucial treatment until weeks after their procedures.

16 Sep 2009

Pilkington receives license to produce SPD-SmartGlass panels

Today at the Frankfurt International Motor Show, Pilkington Group Limited announced that it has acquired a new license from Research Frontiers Inc. to offer SPD-Smart automotive end-products globally.

16 Sep 2009

BIOBASE and Erasmus MC to launch training and application center

BIOBASE GmbH, in cooperation with Erasmus Medical Center (MC), announced today that they will collaborate to establish a Center of Excellence at Erasmus MC for the application of BIOBASE products.

16 Sep 2009

$Heart failure patients with moderate ejection fractions may benefit from CRT$

Heart failure patients with moderate ejection fractions may benefit from CRT

Early findings from a Medtronic, Inc. sponsored study show heart failure patients with moderate ejection fractions, over 35 percent, may receive comparable benefits from cardiac resynchronization therapy (CRT) as compared to those with low ejection fractions of equal to or less than 35 percent.

16 Sep 2009

CMRG achieves 12% healthcare cost savings with Verisk Health’s D2Explorer

Verisk Health, Inc., a global leader in healthcare data analytics, announced today that Core Management Resource Group (CMRG), a benefit-management company for self-funded health insurance programs, successfully implemented care management interventions and individual health risk assessments using Verisk Health’s D2Explorer and achieved 12% healthcare cost savings for one of its employer group clients.

16 Sep 2009

Logical Progression offers complimentary license package of its Logical Ink software to hospitals

Logical Progression, a software company specializing in tablet-based charting for hospitals/clinical trials and visitor management solutions, announced today a special opportunity for hospitals to receive a complimentary license package of its Logical Ink® electronic charting solution for healthcare.

15 Sep 2009

FDA clears Olerup SSP’s Taq-polymerase-free HLA typing kit for sale in the U.S.

Olerup SSP, a wholly owned subsidiary of LinkMed (STO:LMED), has had its Taq-polymerase-free HLA typing kit registered and cleared by the FDA. This means that Olerup SSP’s entire product range for HLA typing, with or without Taq polymerase, can now be marketed and sold to a greater number of healthcare centers in North America.

15 Sep 2009

Free medication reminder service launched for patients

Prescription medications are widely used in the U.S., with 47% of Americans using at least one prescription drug, according to the Center for Disease Control's report "Health, United States, 2008." Prescription drug use is even more widespread among the senior population, with 66% of those in the 45-65 age group and 87% of those aged 65 years and older on prescription medications.

15 Sep 2009

BCLI collaborates with HBI to complete pre-clinical safety experiments

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into a strategic agreement with Harlan Biotech Israel Ltd (HBI), a leading Good Laboratory Practice contractor, in order to complete pre-clinical safety experiments for the company’s innovative therapy for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s disease).

15 Sep 2009

Tripos announces a new program for software developers

Tripos™, a leading provider of drug discovery informatics products and services, today announced the creation of a worldwide Benchware® Pantheon™ Partner Program for software developers.

15 Sep 2009

iMedicor and Transgenomic to develop an educational marketing program for NuroPro

iMedicor and Transgenomic today announced that they have signed an agreement to develop an educational marketing program for NuroPro, Transgenomic’s diagnostic tests for Alzheimer’s and Parkinson’s disease.

15 Sep 2009

Implantable defibrillator therapy not beneficial for women with heart failure

Implantable cardioverter-defibrillators do not appear to be associated with a reduced risk of death in women with advanced heart failure, according to a meta-analysis of previously published research in the September 14 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

15 Sep 2009

Tryton Side Branch Stent used in 250 procedures to treat atherosclerotic lesions

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that the company’s Tryton Side Branch Stent has been used in 250 procedures to treat atherosclerotic lesions at a bifurcation in patients with heart disease.

15 Sep 2009

NMQF launches the P.A.D. Atlas database that maps peripheral arterial disease prevalence by zip code

The National Minority Quality Forum (NMQF), one of the nation's leading voices in the health disparities discussion, is launching the P.A.D. Atlas, a database that maps by zip code peripheral arterial disease (P.A.D.) prevalence down to the street level, with the P.A.D. Coalition and support from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

15 Sep 2009

Mantra medicine tool helps patients in healing process

Dr. Mitchell Earl Gibson, a board-certified medical doctor in High Point, North Carolina, has formed a company that creates mantra and prayer-meditation-based recordings.

15 Sep 2009

Revolutions Medical unveils the enhanced design of Rev Vac safety syringe

Revolutions Medical Corporation ("Revolutions Medical" or the "Company"), producers of the Rev Vac safety syringe, today detailed further the performance and aesthetic improvements to its flagship Rev Vac syringe, and debuted a highly informative product demonstration video.

15 Sep 2009